oxazoles has been researched along with Staphylococcal Skin Infections in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, HP; Flanagan, S; Flattery, A; Gill, C; Liang, L; Liu, J; Tan, C; Wu, J; Xiao, J | 1 |
| Drusano, GL; Lodise, TP | 1 |
| De Anda, C; Fang, E; Green, S; Mehra, P; O'Riordan, W; Prokocimer, P | 1 |
| Das, D; Fang, E; Mehra, P; Prokocimer, P; Tulkens, PM | 1 |
| Burdette, SD; Trotman, R | 1 |
| Chen, KH; Hsueh, PR; Huang, YT; Liao, CH; Sheng, WH | 1 |
| Bassetti, M; Concia, E; Cristini, F; De Rosa, FG; Esposito, S; Menichetti, F; Petrosillo, N; Russo, A; Tumbarello, M; Venditti, M; Viale, P; Viscoli, C | 1 |
| Das, AF; De Anda, C; Fang, E; Prokocimer, P; Sandison, T | 1 |
| Bien, P; Bulitta, JB; Corey, GR; DeAnda, C; Mehra, P; Prokocimer, P; Surber, J | 1 |
| Bartizal, K; Bien, P; Deanda, C; Pillar, CM; Prokocimer, P | 1 |
5 review(s) available for oxazoles and Staphylococcal Skin Infections
| Article | Year |
|---|---|
Use of pharmacokinetic/pharmacodynamic systems analyses to inform dose selection of tedizolid phosphate.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Disease Models, Animal; Humans; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Pneumonia, Staphylococcal; Staphylococcal Skin Infections; Staphylococcus aureus | 2014 |
Tedizolid phosphate for the management of acute bacterial skin and skin structure infections: efficacy summary.
Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Humans; Organophosphates; Oxazoles; Staphylococcal Skin Infections; Treatment Outcome | 2014 |
Tedizolid phosphate for the management of acute bacterial skin and skin structure infections: safety summary.
Topics: Animals; Anti-Bacterial Agents; Clinical Trials as Topic; Disease Models, Animal; Drug-Related Side Effects and Adverse Reactions; Humans; Organophosphates; Oxazoles; Staphylococcal Skin Infections | 2014 |
Tedizolid: The First Once-Daily Oxazolidinone Class Antibiotic.
Topics: Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Drug Interactions; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Staphylococcal Skin Infections | 2015 |
Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections.
Topics: Ambulatory Care; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Glycopeptides; Humans; Lipoglycopeptides; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Teicoplanin; United States; United States Food and Drug Administration | 2016 |
3 trial(s) available for oxazoles and Staphylococcal Skin Infections
| Article | Year |
|---|---|
Clinical Response of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections by Severity Measure Using a Pooled Analysis from Two Phase 3 Double-Blind Trials.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Double-Blind Method; Humans; Linezolid; Organophosphates; Oxazoles; Skin; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes; Young Adult | 2017 |
Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome; Young Adult | 2011 |
In vitro activity and microbiological efficacy of tedizolid (TR-700) against Gram-positive clinical isolates from a phase 2 study of oral tedizolid phosphate (TR-701) in patients with complicated skin and skin structure infections.
Topics: Acetamides; Adolescent; Adult; Aged; Anti-Bacterial Agents; Culture Media; Double-Blind Method; Drug Administration Schedule; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Organophosphates; Oxazoles; Oxazolidinones; Skin; Staphylococcal Skin Infections; Staphylococcus; Tetrazoles | 2012 |
2 other study(ies) available for oxazoles and Staphylococcal Skin Infections
| Article | Year |
|---|---|
Use of Translational Pharmacokinetic/Pharmacodynamic Infection Models To Understand the Impact of Neutropenia on the Efficacy of Tedizolid Phosphate.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Neutropenia; Organophosphates; Oxazoles; Staphylococcal Skin Infections | 2019 |
In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia.
Topics: Acute Disease; Anti-Bacterial Agents; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Pneumonia, Bacterial; Staphylococcal Skin Infections; Streptococcal Infections; Streptococcus agalactiae; Streptococcus anginosus; Streptococcus pyogenes; Taiwan; Vancomycin-Resistant Enterococci | 2015 |